[1]
Rambaldi, A. 2009. How important is to eradicate minimal residual disease in indolent non-Hodgkin’s lymphoma?. Hematology Meeting Reports (formerly Haematologica Reports). 2, 7 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i7.424.